{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T18:33:15Z","timestamp":1785522795760,"version":"3.56.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"vor","delay-in-days":61,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-026-04918-0","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T13:03:35Z","timestamp":1779973415000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Apolipoprotein B is considered a potential therapeutic drug target for the treatment of AML"],"prefix":"10.1007","volume":"17","author":[{"given":"Qi","family":"Meng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanchao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,28]]},"reference":[{"issue":"2","key":"4918_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1159\/000536152","volume":"147","author":"W Franziska","year":"2024","unstructured":"Franziska W, Yana P. Pathophysiology of acute myeloid leukemia. Acta Haematol. 2024;147(2):229.","journal-title":"Acta Haematol"},{"issue":"4","key":"4918_CR2","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s11912-024-01503-y","volume":"26","author":"W Michael","year":"2024","unstructured":"Michael W, Marina K, Shane M. Novel therapeutic targets in acute myeloid leukemia (AML). Curr Oncol Rep. 2024;26(4):409.","journal-title":"Curr Oncol Rep"},{"issue":"2","key":"4918_CR3","doi-asserted-by":"publisher","first-page":"BSR20231720","DOI":"10.1042\/BSR20231720","volume":"44","author":"L Chenyu","year":"2024","unstructured":"Chenyu L, Jingyuan Z, Bingyu K, Shuai L, Jingya T, Deshi D, Yanwei C. Identification and validation of STAT4 as a prognostic biomarker in acute myeloid leukemia. Biosci Rep. 2024;44(2):BSR20231720.","journal-title":"Biosci Rep"},{"key":"4918_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-024-00649-y","author":"Z Yeming","year":"2024","unstructured":"Yeming Z, Guiqin H, Xiaoya C, Ying L, Bingxin Q, Dengju L. Global, regional, and national burden of acute myeloid leukemia, 1990\u20132021: a systematic analysis for the global burden of disease study 2021. Biomark Res. 2024. https:\/\/doi.org\/10.1186\/s40364-024-00649-y.","journal-title":"Biomark Res"},{"key":"4918_CR5","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2024.286018","author":"M Yael","year":"2024","unstructured":"Yael M, JongBok L, Yoosu N, Brandon YL, Nicholas SL, William DG, et al. Acute myeloid leukemia drug-tolerant persister cells survive chemotherapy by transiently increasing plasma membrane rigidity, that also increases their sensitivity to immune cell killing. Haematologica. 2024. https:\/\/doi.org\/10.3324\/haematol.2024.286018.","journal-title":"Haematologica"},{"key":"4918_CR6","doi-asserted-by":"publisher","DOI":"10.1007\/BF00215683","author":"SD S","year":"1992","unstructured":"S SD, R AF, B GB, J DB, J JA, A GM, et al. Association of apolipoprotein B gene variants with plasma apoB and low density lipoprotein (LDL) cholesterol levels. Hum Genet. 1992. https:\/\/doi.org\/10.1007\/BF00215683.","journal-title":"Hum Genet"},{"key":"4918_CR7","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.M200482-JLR200","author":"ET Dawn","year":"2003","unstructured":"Dawn ET, Jane YE, Sara ML, Brian S, P Hugh RB, John RB, et al. Inhibition of both the apical sodium-dependent bile acid transporter and HMG-CoA reductase markedly enhances the clearance of LDL apoB. J Lipid Res. 2003. https:\/\/doi.org\/10.1194\/jlr.M200482-JLR200.","journal-title":"J Lipid Res"},{"key":"4918_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2024.117556","author":"D Takahito","year":"2024","unstructured":"Takahito D, Anne L, B\u00f8rge GN. Remnant cholesterol, LDL cholesterol, and apoB absolute mass changes explain results of the PROMINENT trial. Atherosclerosis. 2024. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2024.117556.","journal-title":"Atherosclerosis"},{"issue":"5","key":"4918_CR9","first-page":"333","volume":"118","author":"DS Allan","year":"2009","unstructured":"Allan DS, Jacqueline DG, Patrick C, Ken W, Robert SK, Gerald FW. Regulation of plasma LDL: the apoB paradigm. Clin Sci (Lond). 2009;118(5):333.","journal-title":"Clin Sci (Lond)"},{"issue":"5","key":"4918_CR10","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1161\/ATVBAHA.123.320175","volume":"44","author":"NW Benjamin","year":"2024","unstructured":"Benjamin NW, Kasper MP, Anders BW, B\u00f8rge GN. Remnant cholesterol, not LDL cholesterol, explains peripheral artery disease risk conferred by apoB: a cohort study. Arterioscler Thromb Vasc Biol. 2024;44(5):1144.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"4918_CR11","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.M300448-JLR200","author":"JT Andr\u00e9","year":"2004","unstructured":"Andr\u00e9 JT, Beno\u00eet L, Isabelle LR, Jean-Charles H, Jean B, Claude G, et al. Increased production of VLDL apoB-100 in subjects with familial hypercholesterolemia carrying the same null LDL receptor gene mutation. J Lipid Res. 2004. https:\/\/doi.org\/10.1194\/jlr.M300448-JLR200.","journal-title":"J Lipid Res"},{"issue":"1","key":"4918_CR12","first-page":"113","volume":"184","author":"LH Kristin","year":"2005","unstructured":"Kristin LH, Ingrid EL, Xian A, Jose MO, Maria Luz F. Associations between plasma lipid parameters and APOC3 and APOA4 genotypes in a healthy population are independent of dietary cholesterol intake. Atherosclerosis. 2005;184(1):113.","journal-title":"Atherosclerosis"},{"issue":"1","key":"4918_CR13","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1186\/s12933-022-01703-5","volume":"21","author":"R Alexia","year":"2022","unstructured":"Alexia R, David M, Laurent L, Bruno V, Thomas G, Benjamin B. Role of apolipoprotein C1 in lipoprotein metabolism, atherosclerosis and diabetes: a systematic review. Cardiovasc Diabetol. 2022;21(1):272.","journal-title":"Cardiovasc Diabetol"},{"key":"4918_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2022.155162","volume":"131","author":"Z Ying","year":"2022","unstructured":"Ying Z, Xiong J, Xiaoyan Y, Xiangli B, Yajing L, Lin Z, Wenzhuo C, Meng S, Yan Z, Xiaolong D, et al. Deacetylation of Caveolin-1 by Sirt6 induces autophagy and retards high glucose-stimulated LDL transcytosis and atherosclerosis formation. Metabolism. 2022;131: 155162.","journal-title":"Metabolism"},{"issue":"2","key":"4918_CR15","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s11883-023-01184-1","volume":"26","author":"JPK John","year":"2023","unstructured":"John JPK, Andrew H, Mary RD, Marc D, Michael HD. Obicetrapib: Reversing the Tide of CETP Inhibitor Disappointments. Curr Atheroscler Rep. 2023;26(2):35.","journal-title":"Curr Atheroscler Rep"},{"issue":"6","key":"4918_CR16","doi-asserted-by":"publisher","first-page":"741","DOI":"10.15252\/embr.201540081","volume":"16","author":"CS Cameron","year":"2015","unstructured":"Cameron CS, Stefania V, Fabrizio V, Berend S, Jorge L, Olivier S, Nicolas G, Dmitry K, Olivier M, Marc C, et al. Wnt directs the endosomal flux of LDL-derived cholesterol and lipid droplet homeostasis. EMBO Rep. 2015;16(6):741.","journal-title":"EMBO Rep"},{"issue":"6803","key":"4918_CR17","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1038\/35035117","volume":"407","author":"K Tamai","year":"2000","unstructured":"Tamai K, Semenov M, Kato Y, Spokony R, Liu C, Katsuyama Y, Hess F, Saint-Jeannet JP, He X. LDL-receptor-related proteins in Wnt signal transduction. Nature. 2000;407(6803):530.","journal-title":"Nature"},{"key":"4918_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-019-1006-7","author":"L Hongrong","year":"2019","unstructured":"Hongrong L, Qifei Z, Liping C, Cong W, Hongying B, Yujie Y, et al. LncRNA MALAT1 modulates ox-LDL induced EndMT through the Wnt\/\u03b2-catenin signaling pathway. Lipids Health Dis. 2019. https:\/\/doi.org\/10.1186\/s12944-019-1006-7.","journal-title":"Lipids Health Dis"},{"key":"4918_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-022-09457-9","author":"Z Guang-Li","year":"2022","unstructured":"Guang-Li Z, Cheng X, Kai-Bin Y, Si-Qi T, Ling-Long T, Lei C, et al. Causal relationship between genetically predicted depression and cancer risk: a two-sample bi-directional mendelian randomization. BMC Cancer. 2022. https:\/\/doi.org\/10.1186\/s12885-022-09457-9.","journal-title":"BMC Cancer"},{"key":"4918_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1452849","author":"F Chong","year":"2024","unstructured":"Chong F, Longquan W, Wenjiao C. IL6 receptor inhibitors: exploring the therapeutic potential across multiple diseases through drug target Mendelian randomization. Front Immunol. 2024. https:\/\/doi.org\/10.3389\/fimmu.2024.1452849.","journal-title":"Front Immunol"},{"key":"4918_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2024.1446610","author":"O Guangyang","year":"2024","unstructured":"Guangyang O, Yi Z, Huzhi C, Kunpeng Y, Zerui Q, Yaowu C, et al. Lipid-lowering drugs, circulating inflammatory factors, and atrial fibrillation: a mediation Mendelian randomization study. Front Cardiovasc Med. 2024. https:\/\/doi.org\/10.3389\/fcvm.2024.1446610.","journal-title":"Front Cardiovasc Med"},{"key":"4918_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2023.02.015","author":"CL John","year":"2023","unstructured":"John CL. Mendelian Randomization: A Powerful Tool to Illuminate Pathophysiologic Mechanisms. Mayo Clin Proc. 2023. https:\/\/doi.org\/10.1016\/j.mayocp.2023.02.015.","journal-title":"Mayo Clin Proc"},{"key":"4918_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s12986-024-00849-1","author":"Z Peng-Fei","year":"2024","unstructured":"Peng-Fei Z, Zhao-Fen Z, Zheng-Yu L, Jin H, Jing-Jing R, Hong-Wei P. HMGCR as a promising molecular target for therapeutic intervention in aortic aneurisms: a mendelian randomization study. Nutr Metab Lond. 2024. https:\/\/doi.org\/10.1186\/s12986-024-00849-1.","journal-title":"Nutr Metab Lond"},{"issue":"1","key":"4918_CR24","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1007\/s12672-024-01565-1","volume":"15","author":"Y Fanhua","year":"2024","unstructured":"Fanhua Y, Hao J, Yena G. Causal relationship between immune cells and acute myeloid leukemia: a two-sample Mendelian randomization study. Discov Oncol. 2024;15(1):675.","journal-title":"Discov Oncol"},{"issue":"9","key":"4918_CR25","doi-asserted-by":"publisher","first-page":"e15157","DOI":"10.1111\/exd.15157","volume":"33","author":"C Zang","year":"2024","unstructured":"Zang C, Li J, Zhang Y, Deng W, Mao M, Zhu W, Chen W. Causal effects of lipid-lowering drugs on inflammatory skin diseases: evidence from drug target Mendelian randomisation. Exp Dermatol. 2024;33(9):e15157.","journal-title":"Exp Dermatol"},{"issue":"5","key":"4918_CR26","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s10654-017-0255-x","volume":"32","author":"S Burgess","year":"2017","unstructured":"Burgess S. Interpreting findings from Mendelian randomization using the MR-Egger method. Eur J Epidemiol. 2017;32(5):377\u201389.","journal-title":"Eur J Epidemiol"},{"key":"4918_CR27","doi-asserted-by":"publisher","first-page":"101805","DOI":"10.1016\/j.mcp.2022.101805","volume":"63","author":"Y Lu","year":"2022","unstructured":"Lu Y, Zhong L, Luo X, Liu C, Dan W, Chu X, Wan P, Zhang Z, Wang X, Liu Z, et al. MiRNA-301b-3p induces proliferation and inhibits apoptosis in AML cells by targeting FOXF2 and regulating Wnt\/\u03b2-catenin axis. Mol Cell Probes. 2022;63:101805.","journal-title":"Mol Cell Probes"},{"issue":"1","key":"4918_CR28","doi-asserted-by":"publisher","first-page":"e2024058","DOI":"10.4084\/MJHID.2024.058","volume":"16","author":"B Altinok Gunes","year":"2024","unstructured":"Altinok Gunes B, Ozkan T, Karadag Gurel A, Dalkilic S, Belder N, Ozkeserli Z, Ozdag H, Beksac M, Sayinalp N, Yagci A, et al. Transcriptome analysis of beta-catenin-related genes in CD34\u2009+\u2009haematopoietic stem and progenitor cells from patients with AML. Med J Hematol Infect Dis. 2024;16(1):e2024058.","journal-title":"Med J Hematol Infect Dis"},{"issue":"22","key":"4918_CR29","first-page":"e2100914","volume":"8","author":"H Yan","year":"2021","unstructured":"Yan H, Wang Z, Sun Y, Hu L, Bu P. Cytoplasmic NEAT1 suppresses AML stem cell self-renewal and leukemogenesis through inactivation of Wnt signaling. Adv Sci (Weinheim Baden-Wurttemberg Germany). 2021;8(22):e2100914.","journal-title":"Adv Sci (Weinheim Baden-Wurttemberg Germany)"},{"key":"4918_CR30","doi-asserted-by":"publisher","DOI":"10.1111\/jpi.12901","author":"A Mohammad Reza","year":"2023","unstructured":"Mohammad Reza A, Fahimeh S, Minoo S, Ahmad K, Mahshid V, Reza N, et al. Angiogenesis, coagulation, and fibrinolytic markers in acute promyelocytic leukemia (NB4): an evaluation of melatonin effects. J Pineal Res. 2023. https:\/\/doi.org\/10.1111\/jpi.12901.","journal-title":"J Pineal Res"},{"issue":"3","key":"4918_CR31","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/s44321-024-00024-2","volume":"16","author":"J Mueller","year":"2024","unstructured":"Mueller J, Schimmer R, Koch C, Schneiter F, Fullin J, Lysenko V, Pellegrino C, Klemm N, Russkamp N, Myburgh R, et al. Targeting the mevalonate or Wnt pathways to overcome CAR T-cell resistance in TP53-mutant AML cells. EMBO Mol Med. 2024;16(3):445\u201374.","journal-title":"EMBO Mol Med"},{"issue":"6","key":"4918_CR32","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s11745-017-4256-z","volume":"52","author":"H Bhuiyan","year":"2017","unstructured":"Bhuiyan H, Masquelier M, Tatidis L, Gruber A, Paul C, Vitols S. Acute myelogenous leukemia cells secrete factors that stimulate cellular LDL uptake via autocrine and paracrine mechanisms. Lipids. 2017;52(6):523\u201334.","journal-title":"Lipids"},{"issue":"6","key":"4918_CR33","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1016\/S0002-9440(10)65706-9","volume":"153","author":"M Rudling","year":"1998","unstructured":"Rudling M, G\u00e5fvels M, Parini P, Gahrton G, Angelin B. Lipoprotein receptors in acute myelogenous leukemia: failure to detect increased low-density lipoprotein (LDL) receptor numbers in cell membranes despite increased cellular LDL degradation. Am J Pathol. 1998;153(6):1923\u201335.","journal-title":"Am J Pathol"},{"issue":"7","key":"4918_CR34","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1021\/mp400759d","volume":"11","author":"M Liu","year":"2014","unstructured":"Liu M, Li W, Larregieu C, Cheng M, Yan B, Chu T, Li H, Mao S. Development of synthetic peptide-modified liposomes with LDL receptor targeting capacity and improved anticancer activity. Mol Pharm. 2014;11(7):2305\u201312.","journal-title":"Mol Pharm"},{"issue":"12","key":"4918_CR35","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1016\/j.exphem.2007.07.017","volume":"35","author":"L Connelly-Smith","year":"2007","unstructured":"Connelly-Smith L, Pattinson J, Grundy M, Shang S, Seedhouse C, Russell N, Pallis M. P-glycoprotein is downregulated in KG1a-primitive leukemia cells by LDL cholesterol deprivation and by HMG-CoA reductase inhibitors. Exp Hematol. 2007;35(12):1793\u2013800.","journal-title":"Exp Hematol"},{"issue":"6","key":"4918_CR36","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1194\/jlr.M012872","volume":"52","author":"M Tadin-Strapps","year":"2011","unstructured":"Tadin-Strapps M, Peterson L, Cumiskey A, Rosa R, Mendoza V, Castro-Perez J, Puig O, Zhang L, Strapps W, Yendluri S, et al. siRNA-induced liver ApoB knockdown lowers serum LDL-cholesterol in a mouse model with human-like serum lipids. J Lipid Res. 2011;52(6):1084\u201397.","journal-title":"J Lipid Res"},{"key":"4918_CR37","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/S0145-2126(97)00097-0","volume":"21","author":"F Vahrenwald","year":"1997","unstructured":"Vahrenwald F, Galka K, J\u00fcrgens G, Bruchelt G, Girgert R, Schweizer P. Toxic reactions of oxidized LDL on cells of acute myeloid leukemia. Leuk Res. 1997;21:1071\u20136.","journal-title":"Leuk Res"},{"issue":"2","key":"4918_CR38","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1093\/cvr\/cvad159","volume":"120","author":"M Borrell-Pages","year":"2024","unstructured":"Borrell-Pages M, Luquero A, Vilahur G, Padr\u00f3 T, Badimon L. Canonical Wnt pathway and the LDL receptor superfamily in neuronal cholesterol homeostasis and function. Cardiovasc Res. 2024;120(2):140\u201351.","journal-title":"Cardiovasc Res"},{"issue":"5","key":"4918_CR39","doi-asserted-by":"publisher","first-page":"632","DOI":"10.3923\/ijp.2023.632.641","volume":"19","author":"Q Su","year":"2023","unstructured":"Su Q, Huang P, Luo X, Zhang P, Li H, He Z, et al. Dihydroartemisinin increases the sensitivity of acute myeloid leukemia cells to cytarabine via the Nrf2\/HO-1 anti-oxidant signaling pathway. Int J Pharmacol. 2023;19(5):632\u201341.","journal-title":"Int J Pharmacol"},{"key":"4918_CR40","doi-asserted-by":"publisher","first-page":"112178","DOI":"10.1016\/j.intimp.2024.112178","volume":"134","author":"F Weilun","year":"2024","unstructured":"Weilun F, Wei S, Weijin F, Shaoli Z, Chunjiang W. Clinical features, treatment, and outcomes of patients with carfilzomib induced thrombotic microangiopathy. Int Immunopharmacol. 2024;134:112178.","journal-title":"Int Immunopharmacol"},{"issue":"5","key":"4918_CR41","doi-asserted-by":"publisher","first-page":"437","DOI":"10.4149\/gpb_2020014","volume":"39","author":"Y Liu","year":"2020","unstructured":"Liu Y, Wei M, Liu G, Song C, Yang M, Cao Z, et al. Silencing protease-activated receptor-2 alleviates ox-LDL-induced lipid accumulation, inflammation and apoptosis via activation of Wnt\/\u03b2-catenin signaling. Gen Physiol Biophys. 2020;39(5):437\u201348.","journal-title":"Gen Physiol Biophys"},{"issue":"8","key":"4918_CR42","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1242\/dev.01117","volume":"131","author":"X He","year":"2004","unstructured":"He X, Semenov M, Tamai K, Zeng X. LDL receptor-related proteins 5 and 6 in Wnt\/beta-catenin signaling: arrows point the way. Development. 2004;131(8):1663\u201377.","journal-title":"Development"},{"issue":"5973","key":"4918_CR43","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1126\/science.1186624","volume":"327","author":"Y Wang","year":"2010","unstructured":"Wang Y, Krivtsov A, Sinha A, North T, Goessling W, Feng Z, Zon L, Armstrong S. The Wnt\/beta-catenin pathway is required for the development of leukemia stem cells in AML. Science (New York NY). 2010;327(5973):1650\u20133.","journal-title":"Science (New York NY)"},{"key":"4918_CR44","doi-asserted-by":"publisher","first-page":"15646","DOI":"10.1038\/srep15646","volume":"5","author":"S Ma","year":"2015","unstructured":"Ma S, Yang L, Niu T, Cheng C, Zhong L, Zheng M, Xiong Y, Li L, Xiang R, Chen L, et al. SKLB-677, an FLT3 and Wnt\/\u03b2-catenin signaling inhibitor, displays potent activity in models of FLT3-driven AML. Sci Rep. 2015;5:15646.","journal-title":"Sci Rep"},{"key":"4918_CR45","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.2147\/OTT.S230873","volume":"13","author":"J Qian","year":"2020","unstructured":"Qian J, Huang X, Zhang Y, Ye X, Qian W. \u03b3-catenin overexpression in AML patients may promote tumor cell survival via activation of the Wnt\/\u03b2-catenin axis. OncoTargets Ther. 2020;13:1265\u201376.","journal-title":"OncoTargets Ther"},{"issue":"2","key":"4918_CR46","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s10654-025-01207-y","volume":"40","author":"L Qianwei","year":"2025","unstructured":"Qianwei L, Dang W, Niklas H, Yanping Y, Maria F, Zhe Z, G\u00f6ran W, Karin ES, Fang F. Lipids, apolipoproteins, carbohydrates, and risk of hematological malignancies. Eur J Epidemiol. 2025;40(2):187.","journal-title":"Eur J Epidemiol"},{"key":"4918_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2024.04.021","author":"L Shiqi","year":"2024","unstructured":"Shiqi L, Sikai L, Dawei W, Xiaoyuan W, Fangyuan H, Liufan Y, et al. Modified lentiviral globin gene therapy for pediatric \u03b2(0)\/\u03b2(0) transfusion-dependent \u03b2-thalassemia: a single-center, single-arm pilot trial. Cell Stem Cell. 2024. https:\/\/doi.org\/10.1016\/j.stem.2024.04.021.","journal-title":"Cell Stem Cell"},{"issue":"5","key":"4918_CR48","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/s10529-025-03630-3","volume":"47","author":"SAJ Eshan Rosly","year":"2025","unstructured":"Eshan Rosly SAJ, Ramesh N, Ahsas T, Kavita G, Solayappan G, Atreyi M, Gaurav P, Neeraj Kumar G, Shivkanya F. Identification and characterisation of subtype-specific anti-N-CoR OSGEP protease in acute myeloid leukaemia (AML-M5) cell lineage. Biotechnol Lett. 2025;47(5):90.","journal-title":"Biotechnol Lett"},{"key":"4918_CR49","doi-asserted-by":"publisher","first-page":"1611747","DOI":"10.3389\/pore.2024.1611747","volume":"30","author":"M Adrienn","year":"2024","unstructured":"Adrienn M, Katalin Be\u00e1ta V, Ferenc E, Mikl\u00f3s U, \u00c1rp\u00e1d I, L\u00e1szl\u00f3 R. The roles of phosphorylation of signaling proteins in the prognosis of acute myeloid leukemia. Pathol Oncol Res. 2024;30:1611747.","journal-title":"Pathol Oncol Res"},{"key":"4918_CR50","doi-asserted-by":"publisher","DOI":"10.14744\/ejmo.2023.35138","author":"AM Zahran","year":"2023","unstructured":"Zahran AM, Zahran ZAM, Gamal DA, Elsayh IKI, Moeen SM, Wahman MM, et al. Disturbed expression of memory T-cell subsets could alter the outcomes in adult acute myeloid leukemia. EJMO. 2023. https:\/\/doi.org\/10.14744\/ejmo.2023.35138.","journal-title":"EJMO"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-026-04918-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-04918-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-04918-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T17:19:14Z","timestamp":1785518354000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-026-04918-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,28]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4918"],"URL":"https:\/\/doi.org\/10.1007\/s12672-026-04918-0","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,28]]},"assertion":[{"value":"15 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Since the data used in our study were all obtained from existing databases, no additional ethical review is required for our research.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have agreed to submit this manuscript for publication in Discover Oncology.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1084"}}